Cargando…

Risk-based Vaccines and the Need for Risk-based Subnational Vaccination Strategies for Introduction

BACKGROUND: Most vaccines in the Expanded Program on Immunization are universal childhood vaccines (eg, measles and rotavirus vaccines). Other vaccines such as typhoid conjugate (TCV) and Japanese encephalitis vaccines are risk based and only used in countries where populations are at risk of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhib, Farzana B, Pecenka, Clint J, Marfin, Anthony A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388704/ https://www.ncbi.nlm.nih.gov/pubmed/32725237 http://dx.doi.org/10.1093/cid/ciaa483

Ejemplares similares

Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies
por: Vodicka, Elisabeth, et al.
Publicado: (2020)

Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries
por: Debellut, Frédéric, et al.
Publicado: (2019)

Introduction of Typhoid Conjugate Vaccines in Africa and Asia
por: Neuzil, Kathleen M, et al.
Publicado: (2019)

Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
por: Jamka, Leslie P, et al.
Publicado: (2019)

A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women
por: Malvolti, Stefano, et al.
Publicado: (2021)

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study
por: Puett, Chloe, et al.
Publicado: (2023)

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study
por: Anderson, John D, et al.
Publicado: (2023)

A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines
por: Luthra, K, et al.
Publicado: (2019)

Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
por: Scotney, Soleine, et al.
Publicado: (2017)

Comparison of Strategies for Typhoid Conjugate Vaccine Introduction in India: A Cost-Effectiveness Modeling Study
por: Ryckman, Theresa, et al.
Publicado: (2021)

Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
por: Baral, Ranju, et al.
Publicado: (2023)

Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
por: Buchwald, Andrea G, et al.
Publicado: (2023)

Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
por: Bagamian, Karoun H, et al.
Publicado: (2019)

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
por: Tevi-Benissan, Carol, et al.
Publicado: (2017)

Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Bangladesh
por: Estivariz, Concepcion F, et al.
Publicado: (2017)

Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction
por: Carey, Megan E, et al.
Publicado: (2019)

Why Do We Need a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules?
por: O’Brien, Katherine L., et al.
Publicado: (2014)

Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings
por: Fu, Rui, et al.
Publicado: (2018)

Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge
por: Meiring, James E, et al.
Publicado: (2019)

Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015
por: Billah, Mallick M., et al.
Publicado: (2017)

Administering Multiple Injectable Vaccines During a Single Visit—Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally
por: Dolan, Samantha B., et al.
Publicado: (2017)

Exceptional Financial Support for Introduction of Inactivated Polio Vaccine in Middle-Income Countries
por: Blankenhorn, Anne-Line, et al.
Publicado: (2017)

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region
por: Gurung, Santosh, et al.
Publicado: (2017)

The Differential Impact of Coadministered Vaccines, Geographic Region, Vaccine Product and Other Covariates on Pneumococcal Conjugate Vaccine Immunogenicity
por: Park, Daniel E., et al.
Publicado: (2014)

Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region
por: Fahmy, Kamal, et al.
Publicado: (2017)

Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015
por: Osadebe, Lynda U., et al.
Publicado: (2017)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

The effect of unobserved preferences and race on vaccination hesitancy for COVID-19 vaccines: implications for health disparities
por: van den Broek-Altenburg, Eline M, et al.
Publicado: (2021)

The Impact of Diabetes and Associated Cardiometabolic Risk Factors on Members: Strategies for Optimizing Outcomes
por: Hoerger, Thomas J., et al.
Publicado: (2008)

Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
por: Soble, Adam, et al.
Publicado: (2020)

Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines
por: Sanneh, Bakary, et al.
Publicado: (2019)

Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction
por: Sonko, Mouhamadou A, et al.
Publicado: (2019)

The Value of Preventive Medicine: A Look at Vaccine Management
por: Armstrong, Edward P., et al.
Publicado: (2007)

Introduction
por: Ross, Jonathan D C, et al.
Publicado: (2011)

Introduction
por: McGill, Janet
Publicado: (2018)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2014)

Etiology of Bacterial Meningitis Among Children <5 Years Old in Côte d’Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction
por: Boni-Cisse, Catherine, et al.
Publicado: (2019)

Human papillomavirus vaccination: where to now?
por: Garland, S M
Publicado: (2011)

The Severe Typhoid Fever in Africa Program Highlights the Need for Broad Deployment of Typhoid Conjugate Vaccines
por: Carey, Megan E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i82dedhhc2nsrguudk1fp1ldci